(0.78%) 5 167.60 points
(0.25%) 38 772 points
(0.92%) 16 304 points
(0.52%) $78.52
(2.57%) $2.20
(1.16%) $2 335.30
(3.65%) $27.66
(-0.01%) $965.20
(-0.02%) $0.929
(-0.37%) $10.83
(-0.13%) $0.796
(-0.11%) $91.35
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
0.17% KRW 58 800
Live Chart Being Loaded With Signals
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally...
Stats | |
---|---|
Volumen de hoy | 0.00 |
Volumen promedio | 75 003.00 |
Capitalización de mercado | 4 517.47B |
EPS | KRW0 ( 2024-03-15 ) |
Próxima fecha de ganancias | ( KRW-245.00 ) 2024-05-09 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW114.36 (0.19%) |
Volumen Correlación
SK bioscience Co.,Ltd. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
SK bioscience Co.,Ltd. Correlación - Moneda/Commodity
SK bioscience Co.,Ltd. Finanzas
Annual | 2023 |
Ingresos: | KRW369.51B |
Beneficio Bruto: | KRW136.40B (36.92 %) |
EPS: | KRW290.65 |
FY | 2023 |
Ingresos: | KRW369.51B |
Beneficio Bruto: | KRW136.40B (36.92 %) |
EPS: | KRW290.65 |
FY | 2022 |
Ingresos: | KRW456.73B |
Beneficio Bruto: | KRW239.61B (52.46 %) |
EPS: | KRW1 596.18 |
FY | 2021 |
Ingresos: | KRW929.00B |
Beneficio Bruto: | KRW570.28B (61.39 %) |
EPS: | KRW5 798.46 |
Financial Reports:
No articles found.
SK bioscience Co.,Ltd.
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico